SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community anticipates a potential ETF, with many expecting a significant pump. The discussion centers around the impact of the ETF on DOGE's price, with some users expressing excitement and readiness for a substantial increase. Broader crypto market recovery narratives and meme coin comparisons are also prevalent in the conversation.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

MFI is trending due to a recently announced $500 million private placement to launch a digital asset treasury strategy, sparking excitement and volatility. The community is actively discussing the potential impact of this move, especially its focus on Bitcoin Cash, while some traders express caution due to the company's history and the volatile nature of digital assets. Bulls anticipate a squeeze due to the low float.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending as traders assess whether the recent climb in the $XBI biotechnology index can continue. Some community members are discussing potential resistance levels and debating entry points, while others express frustration with the persistent downtrend and consider cutting losses. Talk centers around market factors including rates, sector rotation, and potential for overall market correction.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

$SMCX is trending amid discussions about potential recovery timelines and oversold conditions after a recent downturn, with community members weighing the risks and rewards of leveraged exposure to $SMCI. Traders are actively debating bottom-fishing strategies versus waiting for stronger momentum, while considering the impact of market volatility on the ETF. Some investors express concern about potential decay and management.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as biotech stocks experience a sector-wide breakout, fueled by significant buyout activity and increasing AI applications in gene editing and drug discovery. Community discussions highlight the shift from crypto and tech stocks towards biotech, with some eyeing specific price targets and potential shorting opportunities. Others point to technical indicators suggesting it may be overbought.

Sound Group, Inc. is global audio-centric social and entertainment company, which engages in the provision of an audio platform. It focuses on audio entertainment and social networking. The company was founded by Jinnan Lai and Ning Ding in November 2010 and is headquartered in Singapore.

Sound Group Inc - ADR

Sound Group Inc

SOGP is trending as traders discuss potential short squeezes and compare it to other high-flying stocks. Community members are debating the legitimacy of a declared dividend and its impact on the stock's future. Some caution about the risks associated with Chinese ADRs, while others maintain a bullish outlook based on the company's financial performance.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi ($SNY) is trending amidst speculation around potential acquisitions and partnerships, particularly concerning ALT and GUTS. Community members are actively discussing scenarios where Sanofi could expand its pipeline through strategic buyouts, driven by its substantial cash reserves. Recent news, including trial data, FDA actions, and potential market expansions, are also contributing to the increased interest in Sanofi.

UMA is a decentralized financial contracts platform built to enable Universal Market Access.  UMA builds infrastructure for “priceless” financial contracts: DeFi contracts that minimize oracle usage, avoiding many of the security and scalability issues that have plagued decentralized finance. The first contracts built with UMA are priceless synthetic tokens: ERC20 tokens that can track anything while minimizing the need for on-chain price data.  The UMA project token powers the system in two ways:  Governance: UMA token holders govern what types of contracts can access the system, which asset types are supported, and key system parameters and upgrades.  Price requests: the priceless methodology minimizes on-chain price requests but doesn’t eliminate them — when contract interactions are disputed, UMA token holders fulfill price requests via the Data Verification Mechanism, or DVM.  UMA tokens enable the holder to participate in community governance and resolve contract disputes through the DVM. The tokens are not an investment opportunity.

UMA is trending as community members actively discuss potential pumps and price targets, with some highlighting its low supply and recent updates. The project's role in decentralized finance and oracle services is also a key talking point, particularly its work with Polymarket. Some traders are noting technical indicators and potential for further upward movement, while others caution about volatility.

Las Vegas Sands Corp. engages in the development of destination properties. It operates through the Macao and Singapore geographical segments. The Macao segment handles the operations of The Venetian Macao, The Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Macao, and Sands Macao. The Singapore segment includes the Marina Bay Sands. The company was founded by Sheldon Gary Adelson in August 2004 and is headquartered in Las Vegas, NV.

Las Vegas Sands Corp

LVS is trending as community members actively discuss options trading strategies, particularly around call options with a $65 strike price. Some traders are pointing to gains on call options, while others debate the future direction of the stock amid broader discussions about the casino and Macau gaming market. Analyst ratings and price target adjustments are also fueling interest in Las Vegas Sands.

Polygon

Polygon is trending as the community discusses its potential for a significant rally, fueled by Ethereum's movements and anticipation for altcoin season. Discussions include the token's long-term potential and the ongoing migration to POL, with some speculation around possible positive news catalysts. Technical analysis and market sentiment are also contributing to the heightened interest in MATIC.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Frank Rimerman Advisors LLC Takes $228,000 Position in Ionis Pharmaceuticals, Inc. $IONS

Frank Rimerman Advisors LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm...

Leerink Partnrs Has Pessimistic View of IONS FY2026 Earnings

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) - Research analysts at Leerink Partnrs dropped their FY2026 earnings estimates for Ionis Pharmaceuticals in a research report issued on...

Pinnacle Wealth Planning Services Inc. Makes New Investment in Ionis Pharmaceuticals, Inc. $IONS

Pinnacle Wealth Planning Services Inc. bought a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) in the second quarter, according to its most recent filing with the...

Savant Capital LLC Acquires Shares of 5,607 Ionis Pharmaceuticals, Inc. $IONS

Savant Capital LLC bought a new position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the second quarter, according to the company in its most recent filing with the...

Ionis Pharmaceuticals, Inc. $IONS Stock Holdings Increased by Raiffeisen Bank International AG

Raiffeisen Bank International AG raised its position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 35.9% during the 2nd quarter, according to its most recent disclosure with...

Candriam S.C.A. Has $28.64 Million Stock Holdings in Ionis Pharmaceuticals, Inc. $IONS

Candriam S.C.A. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 27.1% during the 2nd quarter, according to the company in its most recent 13F filing...

Ionis Pharmaceuticals (NASDAQ:IONS) Sees Strong Trading Volume - Still a Buy?

Ionis Pharmaceuticals (NASDAQ:IONS) Sees Unusually-High Trading Volume - What's Next...

DAWNZERA (donidalorsen) receives positive opinion from CHMP, recommended for approval in EU for hereditary angioedema (HAE)

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...

Fox Run Management L.L.C. Takes $434,000 Position in Ionis Pharmaceuticals, Inc. $IONS

Fox Run Management L.L.C. acquired a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the second quarter, according to the company in its most recent filing with...

Leerink Partnrs Has Pessimistic View of IONS FY2027 Earnings

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) - Equities research analysts at Leerink Partnrs reduced their FY2027 earnings per share (EPS) estimates for Ionis Pharmaceuticals in a report...

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals is trending due to positive opinions and potential catalysts, with community members calling it a "sleeper" and highlighting potential for growth in the coming years. The stock is also being discussed in relation to competitor Arrowhead, particularly regarding FDA approvals and market share. Recent analyst upgrades and reiterations with price target increases from firms like Leerink Partners and Needham are contributing to the positive sentiment around IONS.

IONS
Ionis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IONS News

IONSIonis Pharmaceuticals Inc